Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
alpha-synuclein
amantadine
anosmia
asymptomatic
atypical
autonomic dysfunction
basal ganglia, infarction
biologic markers
bladder dysfunction
carotid artery disease
carotid artery disease, asymptomatic
carotid artery disease, medical management
carotid artery stenosis
CAT scan, emission
CAT scan, emission, abnormal
cerebral infarction
cerebral infarction, subcortical
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrovascular accident
cerebrovascular disease
cerebrovascular disease, surgical treatment of
complications
constipation
controversies in neurology
dementia
deprenyl
depression
diet
dopamine agonist
dopamine receptor
dyskinesia
dystonia
endarterectomy, carotid
enzyme inhibition
gait disorder
gene
gene mutation
genetic neurologic disorders
genetic screening
gray matter
heralding manifestation
hormone replacement
human genome
Huntington's chorea
Huntington's chorea, presymptomatic detection of
hyperosmia
hypersomnia
hyposmia
imbalance
intellectual deficit
L-dopa
L-dopa, drug interactions with and side effects of
Lewy body
Lewy body disease, diffuse
misdiagnosis
monoamine oxidase inhibitors
mortality
MRI
MRI, abnormal
MRI, diffusion tensor
MRI, functional
neuroleptic, atypical
neurologic disease, diagnoses of
neurologic symptoms
neuropathology
neuroprotective agents
neurotoxic
neurotoxin
orthostatic hypotension
Parkinson disease
Parkinson disease, acute onset
Parkinson disease, arteriosclerotic
Parkinson disease, diagnosis
Parkinson disease, differential diagnosis of
Parkinson disease, early symptoms
Parkinson disease, fluctuations in
Parkinson disease, L-dopa nonresponsive
Parkinson disease, misdiagnosis
Parkinson disease, mode of onset
Parkinson disease, nonmotor problems of
Parkinson disease, on-off phenomena in
Parkinson disease, presymptomatic detection
Parkinson disease, prognosis of
Parkinson disease, surgical treatment of
Parkinson disease, transient
Parkinson disease, treatment of
Parkinson disease, wearing off
Parkinson disease, young onset
Parkinsonism syndrome
pergolide
pramipexole
preclinical
premarin
prevention of neurologic disorders
PRKN gene
prognosis
psychological testing, neurologic problems
psychosis
quetiapine
radiotracer imaging
rasagiline
REM sleep
REM sleep behavior disorder
revascularization, surgical
review article
risk factors
sinemet
single photon emission computed tomography
sleep
sleep pathology and physiology
smell
Smell Identification Test
solvent
stimulation, deep brain
substantia nigra
syncope
synucleinopathy
treatment of neurologic disorder
tremor
tremor, thalamic stimulation for suppression of
trichloroethylene
ultraprocessed foods
walking, difficulty with
watershed infarcts
Showing articles 100 to 150 of 2480 << Previous Next >>

Might Olfactory Dysfunction be a Marker of Early Alzheimer's Disease?
Lancet 355:84-85, Burns,A., 2000

Risks and Benefits of Screening for Intracranial Aneurysms in First-Degree Relatives of Patients with Sporadic Subarachnoid Hemorrhage
NEJM 341:1344-1350, The Magnetic Resonance Angiography in Relatives of, 1999

Intracranial Aneurysms:Detection with Three-Dimensional CT Angiography with Volume Rendering-Comparison with Conventional angiographic and Surgical Findings
Radiology 211:497-506, Korogi,Y.,et al, 1999

Altered Brain Activation in Cognitively Intact Individuals at High Risk for Alzheimer's Disease
Neurol 53:1391-1396, Smith,C.D.,et al, 1999

Mild Cognitive Impairment, Clinical Characterization and Outcome
Arch Neurol 56:303-308, Petersen,R.C.,et al, 1999

Serial Magnetic Resonance Imaging of Cerebral Atrophy in Preclinical Alzheimer's Disease
Lancet 353:2125, Fox,N.C.,et al, 1999

Variability in Annual Mini-Mental State Examination Score in Patients with Probable Alzheimer Disease
Arch Neurol 56:857-862, Clark,C.M.,et al, 1999

Should We Screen for Familial Intracranial Aneurysm?
Stroke 30:312-316, Crawley,F.,et al, 1999

Screening for Dementia with the Memory Impairment Screen
Neurol 52:231-238,224, Buschke,H.,et al, 1999

Preclinical Prediction of Alzheimer's Disease Using SPECT
Neurol 50:1563-1571, Johnson,K.A.,et al, 1998

Risk of Harboring an Unruptured Intracranial Aneurysm
Stroke 29:359-362, Ronkainen,A.,et al, 1998

Genetic Testing of Children at Risk for Huntington's Disease
Neurol 49:1048-1053, Nance,M.A.,et al, 1997

Familial Intracranial Aneurysms
Lancet 349:380-384, Ronkainen,A.,et al, 1997

Few Psychological Consequences of Presymptomatic Testing for Huntington Disease
Lancet 349:4, Bundey,S., 1997

The Clinical Introduction of Genetic Testing for Alzheimer Disease, An Ethical Perspective
JAMA 277:832-836, Post,S.G.,et al, 1997

Motor Changes in Presymptomatic Huntington Disease Gene Carriers
Arch Neurol 53:487-492, Siemers,E.,et al, 1996

High Apolipoprotein E e4 Allele Frequency in Age-Related Memory Decline
Ann Neurol 39:548-551, Blesa,R.,et al, 1996

Three-Dimensional CT Angiography in the Detection and Characterization of Intracranial Berry Aneurysms
AJNR 17:439-445, Hope,J.K.A.,et al, 1996

Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the e4Allele for Apolipoprotein E
NEJM 334:752-758, 7911996., Reiman,E.M.,et al, 1996

Statement of Use of Apolipoprotein E Testing for Alzheimer Disease
JAMA 274:1627-1629, Farrer,L.A.,et al, 1995

Neuropsychological Detection and Characterization of Preclinical Alzheimer's Disease
Neurol 45:957-962, Jacobs,D.M.,et al, 1995

Intracranial Aneurysms:MR Angiographic Screening in 400 Asymptomatic Individuals with Increased Familial Risk
Radiology 195:35-40, Ronkainen,A.,et al, 1995

Outcome in Familial Subarachnoid Hemorrhage
Stroke 26:961-963, Bromberg,J.E.C.,et al, 1995

Eval of the Circle of Willis with Three-Dimentional CT Angiography in Pts with Suspected Intracran Aneurysms
AJNR 16:1571-1578, 15791995., Alberico,R.A.,et al, 1995

A Low, "Normal"Score on the Mini-Mental State Exam Predicts Development of Dementia after Three Years
JAGS 43:656-661, Braekhus,A.,et al, 1995

Reduced Basal Ganglia Volume Associated with the Gene for Huntington's Disease in Asymptomatic at-Risk Persons
Neurol 44:823-828, Aylward,E.H.,et al, 1994

On the Inheritance of Intracranial Aneurysms
Stroke 25:2028-2037, Schievnink,W.I.,et al, 1994

Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
Stroke 25:2315-2328, Mayberg,M.R.,et al, 1994

Occult Intracranial Aneurysms in Polycystic Kidney Disease:Screening with MR Angiography
Radiology 191:33-39, Ruggieri,P.M.,et al, 1994

The Neurogenetic Genie:Testing for Huntington's Disease Mutation
Neurol 44:1369-1373, 1533-15361994., Hersch,S.,et al, 1994

A Worldwide Study of the Huntington's Disease Mutation, The Sensitivity & Specificity of Measuring CAG Repeats
NEJM 330:1401-1406, 14501994., Kremer,B.,et al, 1994

Attitudes Toward Direct Predictive Testing for the Huntington Disease Gene
JAMA 270:2321-2325, Babul,R.,et al, 1993

Experience with Screening Newborns for Duchenne Muscular Dystrophy in Wales
BMJ 306:357-360, 3491993., Bradley,D.M.,et al, 1993

Clinical Consequences of Isolating the Gene for Huntington's Disease
BMJ 307:397-398, Harper,P.S., 1993

Analysis of Dystrophin Expression after Activation of Myogenesis in Amniocytes, Chorionic-Villus Cells, and Fibroblasts
NEJM 329:915-920, Sancho,S.,et al, 1993

Serial Changes of Cerebral Glucose Metab & Caudate Size in Persons at Risk for Huntington's Dis
Arch Neurol 49:1161-1167, Grafton,S.T.,et al, 1992

The Psychological Consequences of Predictive Testing for Huntington's Disease
NEJM 327:1401-1405, 14491992., Wiggins,S.,et al, 1992

Presymptomatic Testing for Huntington's Disease in the United Kingdom
BMJ 304:1593-1596, Tyler,A.,et al, 1992

Three-Dimensional Time-of-Flight MR Angiography in the Evaluation of Cerebral Aneurysms
J Comput Assist Tomogr 14:874-881, Sevick,R.J.,et al, 1990

Attitudes of Mothers to Neonatal Screening for Duchenne Muscular Dystrophy
BMJ 300:1112, Smith,R.A.,et al, 1990

Genetic Testing for Huntington's Disease
BMJ 300:1089-1090, Harper,P.,et al, 1990

Abnormalities of Striatal Projection Neurons and n-Methyl-d-Aspartate Receptors in Presymptomatic Huntington's Disease
NEJM 322:1293-1298, Albin,R.L.,et al, 1990

Predictive Testing for Huntington's Disease, Progress and Problems
BMJ 298:404-405, 1989, Harper,P.S.&Morris,M.J., 1989

Predictive Testing for Huntington's Disease with Linked DNA Markers
Lancet 2:463-466, Brock,D.J.H.,et al, 1989

Problems in Genetic Prediction for Huntington's Disease
Lancet 2:601-603, Morris,M.J.,et al, 1989

Uptake of Presymptomatic Predictive Testing for Huntington's Disease
Lancet 2:603-605, Craufurd,D.,et al, 1989

Adoption and Genetic Prediction for Huntington's Disease
Lancet 2:1069-1070, Morris,M.,et al, 1988

Gene Studies in Newborn Males with Duchenne Muscular Dystrophy Detected by Neonatal Screening
Lancet 2:425-427, Greenberg,C.R.,et al, 1988

Predictive Testing for Huntington's Disease with Use of a Linked DNA Marker
NEJM 318:535-542, Meissen,G.J.,et al, 1988

Presymptomatic Neuropsychological Impairment in Huntington's Disease
Arch Neurol 45:769-773, Jason,G.W.,et al, 1988



Showing articles 100 to 150 of 2480 << Previous Next >>